Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 10
  • Start Date: August 1, 2021
Fitness Intervention Trial in Adults With Sickle Cell Disease (SCD Fit): A Feasibility Study
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Dietary Supplement, Drug
  • Participants: 100
  • Start Date: July 2021
Management of Severe Acute Malnutrition in Children With Sickle Cell Disease Greater Than 5 Years of Age Living in Northern Nigeria
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 9
  • Start Date: May 28, 2021
Transplantation of CRISPRCas9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 20
  • Start Date: May 2021
A Phase 1 Open Labeled Single Ascending Dose Followed by Multiple Dose Safety and Pharmacokinetic Study of HBI-002 Carbon Monoxide Oral Liquid Drug Product in Healthy Adult Volunteers.
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 40
  • Start Date: May 2021
Designing an Implementation Strategy for Delivering Routine Mental Health Screening and Treatment for Adolescents and Adults With Sickle Cell Disease
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug, Other
  • Participants: 200
  • Start Date: May 1, 2021
Study of Montelukast In ChiLdrEn With Sickle Cell Disease (SMILES)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 130
  • Start Date: April 28, 2021
An Open-label, Multi-center, Phase IV, Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 140
  • Start Date: April 20, 2021
An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Vaso-occlusive Crises.
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Radiation
  • Participants: 50
  • Start Date: April 2021
Role of Transcranial Doppler (TCD) in Children With Hemoglobinopathies
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: April 2021
Kinetics of Donor Red Blood Cell Survival in Sickle Cell Disease
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 185
  • Start Date: March 31, 2021
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 1000
  • Start Date: March 23, 2021
A Longitudinal Survey Study on Living With Sickle Cell Disease in the COVID-19 Pandemic
Showing 1-12 of 273